Viewing Study NCT05020704


Ignite Creation Date: 2025-12-24 @ 9:19 PM
Ignite Modification Date: 2025-12-25 @ 7:06 PM
Study NCT ID: NCT05020704
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-04-02
First Post: 2021-08-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: EMpagliflozin to PREvent worSening of Left Ventricular Volumes and Systolic Function After Myocardial Infarction
Sponsor: NHS Greater Glasgow and Clyde
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module